A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis

A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis

Clostridioides difficile infection (CDI) is a common cause of antimicrobial-associated diarrhea. Probiotics have shown variable results in decreasing its incidence and severity. We examined the efficacy of Lactobacillus reuteri administered using a novel probiotic biofilm delivery system in the trea...

Full description

Bibliographic Details
Main Authors: Rita D. Shelby, Grace E. Janzow, Lauren Mashburn-Warren, Jeffrey Galley, Natalie Tengberg, Jason Navarro, Miriam Conces, Michael T. Bailey, Steven D. Goodman, Gail E. Besner
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Gut Microbes
Subjects:
c. difficile
probiotics
lactobacillus reuteri
biofilm
therapeutic treatment
prophylactic treatment
Online Access:http://dx.doi.org/10.1080/19490976.2020.1814119

Internet

http://dx.doi.org/10.1080/19490976.2020.1814119

Similar Items